Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (68)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Poser, S.
Right arrow Articles by Felgenhauer, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poser, S.
Right arrow Articles by Felgenhauer, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 122, No. 12, 2345-2351, December 1999
© 1999 Oxford University Press

Review article

How to improve the clinical diagnosis of Creutzfeldt–Jakob disease

Sigrid Poser1, Brit Mollenhauer1, Angela Krauß1, Inga Zerr1, Bernhard J. Steinhoff2, Andreas Schroeter1, Michael Finkenstaedt3, Walter J. Schulz-Schaeffer4, Hans A. Kretzschmar4 and Klaus Felgenhauer1

1 Departments of Neurology, 2 Neurophysiology, 3 Neuroradiology and 4 Neuropathology, University of Göttingen, Germany

Correspondence to: Professor Dr S. Poser, Klinik für Neurologie, Georg-August-Universität Göttingen, Robert-Koch-Str 40, 37075 Göttingen, Germany

This paper describes a prospective follow-up of 364 patients initially notified as suspected Creutzfeldt–Jakob disease to a Surveillance Unit in Göttingen, Germany. Six patients were diagnosed as having genetic prion disease by blood analysis and were excluded from the study. After examination and review of the remaining 358, 193 were classified as probable Creutzfeldt–Jakob disease. However, autopsy revealed that five of the 193 did not have Creutzfeldt–Jakob disease (four cases, Alzheimer's disease; one case, cerebral lymphoma). Of the 54 patients classified as possible Creutzfeldt–Jakob disease, 10 had another diagnosis made at autopsy. Two of the 111 cases originally classified as having other diseases were found to have Creutzfeldt–Jakob disease on autopsy. Autopsy evidence, together with follow-up of the patients still living and those who died without autopsy, revealed a broad range of other diagnoses. In the younger age groups, the commonest were chronic inflammatory diseases including Hashimoto encephalitis, whilst rapidly progressive Alzheimer's disease was most common in the older age groups. The presence of 14-3-3 protein in the CSF discriminated better between Creutzfeldt–Jakob disease and other rapidly progressive dementias than did the EEG pattern or the MRI. The inclusion of this CSF protein in the criteria of Masters and colleagues (Ann Neurol 1979; 5: 177–88) improves the accuracy and confidence in the clinical diagnosis of Creutzfeldt–Jakob disease.

Creutzfeldt–Jakob disease; Alzheimer's disease; Hashimoto encephalitis; differential diagnosis; 14-3-3 protein


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BrainHome page
I. Zerr, K. Kallenberg, D. M. Summers, C. Romero, A. Taratuto, U. Heinemann, M. Breithaupt, D. Varges, B. Meissner, A. Ladogana, et al.
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease
Brain, October 1, 2009; 132(10): 2659 - 2668.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
M. D. Geschwind, K. M. Tan, V. A. Lennon, R. F. Barajas Jr, A. Haman, C. J. Klein, S. A. Josephson, and S. J. Pittock
Voltage-Gated Potassium Channel Autoimmunity Mimicking Creutzfeldt-Jakob Disease
Arch Neurol, October 1, 2008; 65(10): 1341 - 1346.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P. Brown
Transmissible spongiform encephalopathy in the 21st century: Neuroscience for the clinical neurologist
Neurology, February 26, 2008; 70(9): 713 - 722.
[Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
H.J. Tschampa, K. Kallenberg, H.A. Kretzschmar, B. Meissner, M. Knauth, H. Urbach, and I. Zerr
Pattern of Cortical Changes in Sporadic Creutzfeldt-Jakob Disease
AJNR Am. J. Neuroradiol., June 1, 2007; 28(6): 1114 - 1118.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
U. Heinemann, A. Krasnianski, B. Meissner, D. Varges, K. Kallenberg, W. J. Schulz-Schaeffer, B. J. Steinhoff, E. M. Grasbon-Frodl, H. A. Kretzschmar, and I. Zerr
Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance
Brain, May 1, 2007; 130(5): 1350 - 1359.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
H. J. Tschampa, K. Kallenberg, H. Urbach, B. Meissner, C. Nicolay, H. A. Kretzschmar, M. Knauth, and I. Zerr
MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement
Brain, September 1, 2005; 128(9): 2026 - 2033.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
D. S. Knopman, B. F. Boeve, and R. C. Petersen
Essentials of the Proper Diagnoses of Mild Cognitive Impairment, Dementia, and Major Subtypes of Dementia
Mayo Clin. Proc., October 1, 2003; 78(10): 1290 - 1308.
[Abstract] [PDF]

Home page
 NeurologyHome page
N. Huang, S. K. Marie, J. A. Livramento, R. Chammas, and R. Nitrini
14-3-3 protein in the CSF of patients with rapidly progressive dementia
Neurology, August 12, 2003; 61(3): 354 - 357.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
M. D. Geschwind, J. Martindale, D. Miller, S. J. DeArmond, J. Uyehara-Lock, D. Gaskin, J. H. Kramer, N. M. Barbaro, and B. L. Miller
Challenging the Clinical Utility of the 14-3-3 Protein for the Diagnosis of Sporadic Creutzfeldt-Jakob Disease
Arch Neurol, June 1, 2003; 60(6): 813 - 816.
[Abstract] [Full Text] [PDF]

Home page
 J. Neuropsychiatry Clin. Neurosi.Home page
K. H. Taber, P. Cortelli, W. Staffen, and R. A. Hurley
The Expanding Role of Imaging in Prion Disease
J Neuropsychiatry Clin Neurosci, November 1, 2002; 14(4): 371 - 376.
[Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
Y. Mao-Draayer, S. P. Braff, K. J. Nagle, W. Pendlebury, P. L. Penar, and R. E. Shapiro
Emerging Patterns of Diffusion-Weighted MR Imaging in Creutzfeldt-Jakob Disease: Case Report and Review of the Literature
AJNR Am. J. Neuroradiol., April 1, 2002; 23(4): 550 - 556.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
A. A. Rabinstein, M. L. Whiteman, and R. T. Shebert
Abnormal Diffusion-Weighted Magnetic Resonance Imaging in Creutzfeldt-Jakob Disease Following Corneal Transplantations
Arch Neurol, April 1, 2002; 59(4): 637 - 639.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J.A. Beck, S. Mead, T.A. Campbell, A. Dickinson, D.P.M.W. Wientjens, E.A. Croes, C.M. Van Duijn, and J. Collinge
Two-octapeptide repeat deletion of prion protein associated with rapidly progressive dementia
Neurology, July 24, 2001; 57(2): 354 - 356.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
H J Tschampa, M Neumann, I Zerr, K Henkel, A Schroter, W J Schulz-Schaeffer, B J Steinhoff, H A Kretzschmar, and S Poser
Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease
J. Neurol. Neurosurg. Psychiatry, July 1, 2001; 71(1): 33 - 39.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
D. S. Knopman, S. T. DeKosky, J. L. Cummings, H. Chui, J. Corey-Bloom, N. Relkin, G. W. Small, B. Miller, and J. C. Stevens
Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurology, May 8, 2001; 56(9): 1143 - 1153.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
T. Chapman, D. W. McKeel Jr., and J. C. Morris
Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease
Neurology, November 14, 2000; 55(9): 1396 - 1398.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.